Genetic deletion of miR-34a effectively reduced the BBB leakage, alleviated the disruption of tight junction proteins ZO-1, claudin-5, and occludin, and improved neurological recovery following ischemic stroke [69]. The gene discussed is CLDN5; the disease is ischemic stroke.